Dr. Dinesh Bhurani

Professional Journey

Achievements

• First DM of Haematology in India
• First to perform Haplo Transplant in North India
• Credited with the maximum number of MUD Transplants in North India
• Credited with the start of multiple pioneer works in field of Haemato-oncology and organized much training in this field at global level.

Awards

• The Eddie Hirst Memorial Prize awarded for Pathological Sciences at The Royal College of Pathologist, Australia
• Successful participation in CME titled “Lymphoma B-Cell ” at University of Nebraska Medical Centre, American School for Continuing Medical Education

Publication

• Risk of Mortality in Bone Marrow Transplant Patients During SARS-CoV-2 Infection: A Systematic Review. Sonali Karhana, Kainat Hussain, Garzain Bint-e-Attar, Dinesh Bhurani, Mohd. Ashif Khan, Jan 2023, Experimental and Clinical Transplantation
• Immunosuppression Boost with Mycophenolate Mofetil for Mixed Chimerism in Thalassemia Transplants. Pallavi Mehta, Aakanksha Singh, Rohan Halder, Megha Verma, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani. Feb 2023, Transplantation and Cellular Therapy
• HIV Associated Lymphomas: A Double-Edged Sword, Reema Singh, Jyotsna Kapoor, Nisha Panwar, Sujay Rainchwar, Pritish Chandra Patra, Rohan Halder, Rayaz Ahmed, Narendra Agrawal & Dinesh Bhurani, Mar 2023, Indian Journal of Hematology and Blood Transfusion [IJHBT] IF: 0.915
• Temporal Changes in SARS-CoV-2 Infection Pattern in Patients Admitted with Hematological Diseases—A Single Center Experience from North India, Rohan Halder, Dipti Talaulikar, Reema Singh, Nidhi Menon, Bhaarat Folbs, Pallavi Mehta, Jyotsna Kapoor, Vishvdeep Khushoo, Megha Verma, Nitin Bansal, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani, Mar 2023, Hemato
• Short-Term Impact of Hematopoietic Stem Cell Transplantation in Leukemia Patients on Bone Bio Markers, Electrolytes and Blood Profile, Rhythm Joshi, Zehva Khan, Aakriti Garg, Nidhi, Ubada Aqeel, Dinesh Bhurani, Mohd. Ashif Khan, April 2023, OBM Transplantation
• Short-Term Impact of Hematopoietic Stem Cell Transplantation on Depressive Behaviour, Cognition and Quality of Life in Leukemia Patients, Rhythm Joshi, Aakriti Garg, Zehva Khan, Dinesh Bhurani, Nidhi & Mohd Ashif Khan, April 2023, Indian Journal of Hematology & Blood Transfusion
• Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India, Ankit Patel, Niraj Bhatt, S. S. Prakash, Ghanashyam Biswas, Rajnish Nagarkar, Bodhisatta Roy, Priyanka Samal, Narendra Agrawal, Sushil Meshram, Ashish Kaushal, C. T. Satheesh, Ravikumar Wategaonkar, Kasi Viswanathan Thiagarajan, Kartikeya Jain, P. Vijayaveeran, Kalyan Mukherjee , Kishore Singh, Tushar Patil, Amit Jain, Tuphan Kanti Dolai, Minish Jain, Sachin Hingmire, Tara Chand Gupta, K. C. Lakshmaiah, Deepan Rajamanickam, Bhushan Nemade, Vikash Goyal, Pinaki Mahato, Sanjeev Kumar Mendiratta & Maulik Doshi, April 2023, Cancer Chemotherapy and Pharmacology
• Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method. Vikram Mathews, Anu Korula, Anupam Chakrapani, Dinesh Bhurani, Jina Bhattacharyya, Manju Sengar, Pankaj Malhotra, Pavan Kumar Boyella, Pawan Kumar Singh, Prasanth Ganesan, Rishi Dhawan, Sameer Melinkeri, Sharat Damodar, Tuphan Kanti Dolai, Venkatraman Radhakrishnan. April 2023, Frontiers in Oncology
• Defibrotide prophylaxis for prevention of Sinusoidal Obstruction Syndrome (SOS), Rohan Halder, Varsha Mishra, Tribikram Panda, Narendra Agrawal, Dinesh Bhurani, May 2023, The Lancet hematology [IF: 30.15]
• FLAG based v/s Standard 3+7 induction therapy in treatment naïve Acute Myeloid Leukemia: Time to think “beyond anthracyclines”, Mohd. Rizwan Shaikh, Bhumika Singh, Rohan Halder, Reema Singh, Mohd Riyan Shaikh, Narendra Agarwal, Nitin Bansal, Rayaz Ahmed, Sumeet Prakash Mirgh, Dinesh Bhurani, June 2023, Leukemia Research [IF: 3.715]
• Wernicke’s encephalopathy: a rare but avoidable neurological complication associated with allogeneic stem cell transplant, Sujay, Pritish, Reema, Narendra, Rayaz, Dinesh Bhurani, June 2023, International Journal of Bloor Research and Disorders
• Myasthenia Gravis: A Rare and Unusual Side Effect of Long Term Desferral Chelation, Aakanksha Singh, Rohan Halder, Varsha Mishra, Tribikram Panda, Narendra Agrawal & Dinesh Bhurani, June 2023, Indian Journal of Paediatrics
• End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL- may be the way forward, Pritish Chandra Patra, Sujay Rainchwar, Reema Singh, Rohan Halder, Pallavi Mehta, Megha Verma, Rayaz Ahmed, Jyoti Shankar Raichaudhuri, Dinesh Bhurani, Narendra Agrawal, Suman Pramanik, June 2023, Blood Research
• Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant, Pallavi Mehta, Aakanksha Singh, Rohan Halder, Ankit Jain, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani, Aug 2023, South Asian Journal of Cancer.
• Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis, Neha Yadav, Sumeet P Mirgh, Mukul Aggarwal, Narendra Agrawal, Pallavi Mehta, Vishvdeep Khushoo, Jyotsna Kapoor, Niharika Bhatia, Pragya Agrawal, Rayaz Ahmed, Dinesh Bhurani, 2023, Indian Journal of Cancer [IF: 1.0]
• Improved Outcomes of Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults (AYA) Treated with Modified COG0232, a Paediatric-Inspired Intensive Regimen. Panda, T., Rainchwar, S., Singh, R., Jegan, K. R., Goswami, S., Pillai, R. H et. al. 2023, Clinical Lymphoma Myeloma and Leukemia [IF: 2.02]
• Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical Hodgkin’s lymphoma and primary mediastinal B cell lymphoma, Panda, T., Rainchwar, S., Halder, R. et al. 2023, Annals of Hematology [IF: 4.03]
• Acute Lymphoblastic Leukemia With t (1; 19) (q23; p13)/TCF3-PBX1 in Adolescents and Adults as a Poor Prognostic Marker of Long-Term Outcome: An Indian Tertiary Care Center Experience, Panda, T., Rainchwar, S., Singh, R., Jegan, K. R., Goswami, S., Pillai, R. H et. al. 2023, Clinical Lymphoma Myeloma and Leukemia [IF: 2.02]
• The Interaction Effects of Age of the Patients and Stages of the Disease on Hope among Hematology Cancer Patients A Two-way Analysis of Varriance. Sapna Paliwal, Rita Kumar, Dinesh Bhurani, Reema Singh. Oct 2023, Tuijin Jishu/Journal of Propulsion Technology
• Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era. Reena Nair, Gull Mohammad Bhat, Narendra Agrawal, Manju Sengar, Pankaj Malhotra, Soniya Nityanand, Chitra Lele, Pramod Reddy, Suresh Kankanwadi, Narendra Maharaj. Oct 2023, Frontiers in Oncology
• Effect of antibiotic de-escalation on clinical outcomes in patients with carbapenem-resistant Enterobacteriaceae bacteremia (CRE) in the hematology-oncology setting. Nitin Bansal, Neelam Sachdeva, Dinesh Bhurani, Narendra Agarwal, Rayaz Ahmed, Pallavi Mehta, Rohan Halder, Nov 2023, Germs.
• Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma— a tertiary cancer center experience. Anindya Mukherjee, Sujay Rainchwar, Aakanksha Singh, Rohan Halder, Pritish Chandra Patra, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal, Nov 2023, Blood Research.
• Tuberculosis and Hematological Malignancies: Real World Experience and Key Insights into Drug-Drug Interactions, Abhinav Dewan, Reema Singh, Ishita Sachdeva1, Dinesh Bhurani, Narendra Agrawal, Rayaz Ahmed, Rohan Halder, Pritish Chandra Patra, Sunil Ramrao Debadwar, Nitin Bansal, Nov’2023, Journal of Clinical Infectious and Disease Society
• Recommendations for the treatment and management of adult B-Cell acute lymphoblastic leukemia in Asia-Pacific: Outcomes from a pilot initiative. Zhentang Lao, Kwong Yok Lam, Yuk Man Carol Cheung, Chieh-Lin Teng, Vivek Radhakrishnan, Dinesh Bhurani, Bor-Sheng Ko, Yeow Tee Goh, Dec 2023, Asia Pacific Journal of Clinical Oncology.
• Acute pancreatitis in Thalassemia post allogeneic stem cell transplant with Cyclosporine-A as a possible etiology: a report of two cases, Mohd Rizwan Shaikh, Bhaarat Folbs, Pallavi Mehta, Rohan Halder, Reema Singh, Vishvdeep Khushoo, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal, 2022, International Journal of Clinical Images and Medical Reviews
• Retrospective Study of Treatment Free Remission in Patients with Chronic Myeloid Leukaemia (CML) Treated at Tertiary Care Oncology Centre from India., Megha Verma1, Rohan Halder1, Reema Singh1, Pallavi Mehta1, Narendra Agrawal1, Rayaz Ahmed1, Dinesh Bhurani, Aug 2022, Blood 2022
• Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia. Reema Singh1, Rohan Halder1, Megha Verma1, Pallavi Mehta1, Narendra Agrawal1, Rayaz Ahmed1, Dinesh Bhurani1, Aug 2022, Blood 2022
• An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase, Reema Singh1, Rohan Halder1, Jyotsna Kapoor1, Megha Verma1, Pallavi Mehta1, Narendra Agrawal1, Rayaz Ahmed1, Dinesh Bhurani1, Aug 2022, Blood 2022
• Maintenance with Hypomethylating Agents Post-transplant in Acute Myeloid Leukemia patients: Safe and Affordable Way to Induce Graft Versus Leukemia Effect., Pallavi Mehta, Sujay Rainchwar, Narendra Agrawal; Rayaz Ahmed, Aug 2022, Blood 2022
• Haploidentical stem cell transplantation for hematological disorders: Real world experience from India, Pallavi Mehta; Neha Yadav; Narendra Agrawal; Rayaz Ahmed, Sep 2022, Blood 2022
• Is old still gold for allogeneic transplants in transfusion dependent beta-thalassemia of all risk categories, in the 21st century?: Experience with Fludarabine/Busulfan/Cyclophosphamide/AntiThymocyteGlobulin conditioning with bone marrow graft. Pallavi Mehta; Neha Yadav; Narendra Agrawal; Rayaz Ahmed, Sep 2022, Blood 2022
• Pneumocystis Jirovecii Pneumonia [PJP]: An Unrecognized Concern in AML patients on Venetoclax, SujayRainchwar,RohanHalder ReemaSingh,PallaviMehta MeghaVerma,NarendraAgrawal RayazAhmed,DineshBhurani NitinBansal, Aug 2022, Leukemia Research
• Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis, Meghavi Kathpalia, Pinki Mishra, Ram Bajpai, Dinesh Bhurani & Nidhi Agarwal, Jun 2022, Annals of Hematology
• Imatinib and Patient-Related Outcomes in Chronic Myeloid Leukemia: A Single Centric Experience, Avinash Kumar Singh, Mohammad Azharuddin, Narendra Agrawal, Dinesh Bhurani, Rayaz Ahmed & Manju Sharma , Jul 2022, Comprehensive Clinical Medicine
• Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India, Dinesh Bhurani, Reena Nair, Senthil Rajappa, Suparna Ajit Rao, Nithya Sridharan, Rakesh Reddy Boya, Ganapathi S. Raman, Hari Menon, Arun Seshachalam, and Ramesh Nimmagadda, Feb 2022, Frontiers in Oncology
• Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India, Manish Sharma, Pankaj Goyal, Rajesh Ranjan, Udip Maheshwari, Dinesh Bhurani, Chaturbhuj Aggarwal, Venkata Pradeep Babu Koyyala, Parveen Jain, Narendra Agrawal, Rayaz Ahmed, Udip Maheshwari, Jul 2022, Cureus
• Busulfan (Bu) and Cyclophosphamide (Cy) based conditioning regimen still holds the promise of being a safe and efficacious regimen for Allogeneic Transplantation in patients with Transfusion Dependent Thalassemia (TDT), even in high risk , PallaviMehta, Aakanksha ASingh1NehaYadav1NarendraAgrawal1RayazAhmed1VishvdeepKhushoo1DineshBhurani, Dec 2021, Blood
• Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study Amol N. Patil,Aditya Jandial, Alka Khadwal,Gaurav Prakash, Arihant Jain, Dinesh Bhurani, Rayaz Ahmed, Narendra Agrawal, Reema Singh, Man Updesh Singh Sachdeva, Neelam Varma, Reena Das, Savita Verma Attri, Samir Malhotra, Navneet S. Majhail, Pankaj Malhotra, Deepesh P. Lad, Mar 2022, Leukemia & Lymphoma
• Candida Empyema in Febrile Neutropenia – Augmented value of direct inoculation into BacT/Alert blood culture, NitinBansal, NeelamSachdeva, DineshBhurani, NarendraAgarwal, RohanHalder, PankajGoyal, Nitin Bansal, Neelam Sachdeva, Aug 2022, Indian Journal of Medical Microbiology
• Prevalence of anemia among chronic myeloid leukemia patients treated with Imatinib: A evidence based meta-analysis, Avinash Kumar Singh , Anup Kumar, Narendra Agrawal, Dinesh Bhurani, Rayaz Ahmed & Manju Sharma, Mar 2022, Current Reviews in Clinical and Experimental Pharmacology,
• Role of Cytokines in Chemotherapy Related Cognitive Impairment of Breast Cancer Patients: A Systematic Review, Kanika Tyagi, Md. Masoom, Haya Majid, Aakriti Garg, Dinesh Bhurani, Nidhi Agarwal, Md. Asif, Mar 2022, Current Reviews in Clinical and Experimental Pharmacology
• Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry, Reena Nair, 1 , Dinesh Bhurani, 2 Senthil Rajappa, 3 Asha Kapadia, 4 Rakesh Reddy Boya, 5 Subramanian Sundaram, 6 Hari Menon, 7 Ganapathi S. Raman, 8 Arun Seshachalam, 9 and Ramesh Nimmagadda, Feb 2022, Frontiers in Oncology
• Respiratory Viral Infections in Cancer Patients: Epidemiological, Clinical and Cost-Effectiveness study from a Developing Country, Nitin Bansal, Neelam Sachdeva, Dinesh Bhurani, Gauri Kapoor, Pinky Yadav, Sumit Goyal, Vineet Talwar, Ullas Batra, Jan 2022, Research Square
• Attenuated Dose Dasatinib in newly diagnosed chronic myeloid leukemia chronic phase patients in India.   Rayaz Ahmed1, Reema Singh1, Megha Verma1, Narendra Agrawal1, Rayaz Ahmed1, Dinesh Bhurani1, Rohan Halder, Nov 2022, Clinical Lymphoma Myeloma & Leukemia
• Busulfan (Bu) and Cyclophosphamide (Cy) based conditioning regimen still holds the promise of being a safe and efficacious regimen for Allogeneic Transplantation in patients with Transfusion Dependent Thalassemia (TDT), even in high risk, Pallavi Mehta, Aakanksha Singh, Neha Yadav, Narendra Agrawal, Rayaz Ahmed, Vishvdeep Khushoo, Dinesh Bhurani, MAY/22, EJH
• Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy, Mohd Ashif Khan, Dinesh Bhurani, Ubedul Hoda, Nouroz Sehar, Nidhi Agarwal Oct 2022, Arquivos de Neuro-psiquiatria
• An ‘Uncommon early lineage switch’ in an MLL rearranged adult B-lineage Acute Lymphoblastic Leukemia to Mixed-phenotypic acute leukemia (B/Myeloid). Jyotsna Kapoor; Mohd Rizwan Shaikh; Narender Tejwani; Reema Singh; Vishvdeep Khushoo; Rohan Halder; Pallavi Mehta; Aakanksha Singh; Bhaarat; Sujay Rainchwar; Rayaz Ahmed; Dinesh Bhurani; Narendra Agrawal, 2022, International Journal of Clinical Images and Medical Reviews
• High Risk Acute Promyelocytic Leukemia – An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol. Jyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal, Vishvdeep Khushoo, Narender Tejwani, Reema Singh, Pallavi Mehta, Dinesh Bhurani, Rayaz Ahmed. April 2022, Indian Journal of Hematology & Blood Transfusion
• Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India. Pallavi Mehta, Neha Yadav, Bhaarat Folbs, Jyotsna Kapoor, Vishvdeep Khushoo, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani. 2022, Indian Journal of Hematology and Blood Transfusion

• Published Papers 2021
• Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: Multicenter Retrospective Analysis, Agrawal, N., Singh, R., Sharma, S. K., Naithani, R., Bhargava, R., Choudhary, D., & Bhurani, D. (2021), Indian Journal of Hematology and Blood Transfusion, 1-6.
• Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients, Bhurani, D., Kapoor, J., Yadav, N., Khushoo, V., Agrawal, N., Ahmed, R., & Mehta, P. (2021), Annals of Hematology, 100(6), 1417-1427.
• Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out. Kapoor, J., Mirgh, S. P., Khushoo, V., Mehta, P., Ahmed, R., Bansal, N., … & Agrawal, N. (2021). Therapeutic Advances in Infectious Disease, 8, 20499361211008674.
• An “impossible” harvest–GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma, Kapoor, J., Khushoo, V., Garg, A., Naim, F., Bhatia, N., Folbs, B., … & Mirgh, S. P. (2021). Bone Marrow Transplantation, 1-3.
• Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC). Ganesan, P., Jain, H., Bagal, B., Subramanian, P. G., George, B., Korula, A., … & Sengar, M. (2021). British journal of haematology, 193(1), e1.
• Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies Jeyaraman, P., Agrawal, N., Bhargava, R., Bansal, D., Ahmed, R., Bhurani, D., … & Group, D. H. (2021).. Transfusion and Apheresis Science, 103075.
• Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era, Sharma, A., Ahmed, R., Agrawal, N., Kapoor, J., Sharma, A., Khushoo, V., … & Mirgh, S. P. (2021).. Indian Journal of Hematology and Blood Transfusion, 37(2), 240-248.
• Study of Three Cases of Primary Refractory T Cell ALL, Singh, R., Tejwani, N., Agrawal, N., Kapoor, J., Khushoo, V., Mehta, P., & Bhurani, D. (2021).. Indian Journal of Hematology and Blood Transfusion, 1-3.
• Frontline Healthcare workers suffering from psychosomatic disorders during COVID-19 (a pandemic) – A Systematic review, Rhythm Joshi, Nidhi.B. Agarwal, Dinesh Bhurani, Mohd Ashif Khan, BMJ Yale
• Blood biochemical parameters as predictors of disease severity and mortality in COVID-19 patients- an updated systematic review and meta-analysis, Afsha Majid, Pinki Mishra, Rizwana Parveen, Ram Bajpai, Mohd. Ashif Khan, Nidhi Bharal Agarwal, BMJ Yale
• Efficacy of sirolimus for treatment of autoimmune lymphoproliferative syndrome: a systematic review of open label clinical studies, Sciences, Centre for Translational & Clinical Research, Jamia Hamdard, New Delhi, India, Shweta Sharma, Md. Sarfaraj Hussain, Nidhi.B. Agarwal, Dinesh Bhurani, Mohd Ashif Khan, Md Aejaz Ahmad Ansari, April 2021, Expert opinion on orphan drugs
• An “impossible” harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma. 2021, Jyotsna Kapoor, Vishvdeep Khushoo, Ambar Garg, Faran Naim, Niharika Bhatia, Bhaarat Folbs, Pallavi Mehta, Rayaz Ahmed, Narendra Agrawal, Dinesh Bhurani, Sumeet Prakash Mirgh. 2021, Bone Marrow Transplant [BMT]
• Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies. Preethi Jeyaraman, Narendra Agrawal, Rahul Bhargava, Divya Bansal, Rayaz Ahmed, Dinesh Bhurani, Sachin Bansal, Neha Rastogi, Pronamee Borah, Rahul Naithani. 2021, Transfusion and Apheresis Sciences
• Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin’s Lymphoma (High Grade). Doval DC, Bhurani D, Nair R, Gujral S, Malhotra P, Ramanan G, Mohan R, Biswas G, Dattatreya S, Agarwal S, Pendharkar D, Julka PK, Advani SH, Dhaliwal RS, Tayal J, Sinha R, Kaur T, Rath GK. Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):51-58. doi: 10.4103/0971-5851.203500. Review.

• Epidemiology and resistance pattern of bacterial isolates among cancer patients in a Tertiary Care Oncology Centre in North India. Batra U, Goyal P, Jain P, Upadhyay A, Sachdeva N, Agarwal M, Bhurani D, Talwar V, Gupta SK, Doval DC. Indian J Cancer. 2016 Jul-Sep;53(3):448-451. doi: 10.4103/0019-509X.200647.

• Coexistent Multiple Myeloma and SLL: A Rare Entity. Tanwar P, Jain S, Mehta A, Bhurani D, Agrawal N, Ahmed R. Indian J Hematol Blood Transfus. 2017 Mar;33(1):123-125. doi: 10.1007/s12288-016-0723-6. Epub 2016 Sep 17. No abstract available.

• Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference. Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S, Menon H, Kumar L, Varma N, Varma S, Saikia T, Malhotra P; for IMAGe Group.. Indian J Hematol Blood Transfus. 2017 Mar;33(1):15-21. doi: 10.1007/s12288-016-0773-9. Epub 2017 Jan 2. Review.

• Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine.
  India and Ukraine Haemato-oncology Group., Garg A, Morgunskyy M, Belagali Y, Gupta N, Akku SP. Front Oncol. 2016 Nov 21;6:243. eCollection 2016.

• Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy. Khan MA, Garg K, Bhurani D, Agarwal NB. Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1253-1265. Epub 2016 Aug 27.

• Alteration of Thyroid Function in Indian HER 2-Negative Breast Cancer Patients Undergoing Chemotherapy. Khan MA, Bhurani D, Agarwal NB. Asian Pac J Cancer Prev. 2015;16(17):7701-5.

• Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study. Hsu LY, Lee DG, Yeh SP, Bhurani D, Khanh BQ, Low CY, Norasetthada L, Chan T, Kwong YL, Vaid AK, Alejandria I, Mendoza M, Chen CY, Johnson A, Tan TY. Clin Microbiol Infect. 2015 Jun;21(6):594.e7-11. doi: 10.1016/j.cmi.2015.02.019. Epub 2015 Mar 5.

• Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A,  Bhurani D. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1):e2015013. doi: 10.4084/MJHID.2015.013. eCollection 2015.

• Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry-based study from India. Nimmagadda RB, Digumarti R, Nair R, Bhurani D, Raina V, Aggarwal S, Patil S, Gogoi PK, Sundaram S, Goswami C, Apte S, Chakravarthy S, Pathak A. Indian J Med Paediatr Oncol. 2013 Oct;34(4):299-304. doi: 10.4103/0971-5851.125250.

• Treatment of myelodysplastic syndrome transforming into acute myelogenous leukemia with azacytidine: a retrospective study from cancer centre in northern India. Suresh P, Sharma A,  Bhurani D. Indian J Hematol Blood Transfus. 2010 Sep;26(3):114. doi: 10.1007/s12288-010 0017-3. Epub 2010 Oct 19. No abstract available.

• Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand. Bhurani D, Schifter M, Kerridge I. Bone Marrow Transplant. 2008 Oct;42(8):547-50. doi: 10.1038/bmt.2008.197. Epub 2008 Jul 14.

• The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S. Haematologica. 2006 Jul;91(7):972-5.
• Successful surgical hemostasis in patients with von Willebrand disease following infusion of Koate DVI. Srivastava A, Mathews V, Bhurani D, Baidya S, Chandy M. Thromb Haemost. 2002 Mar;87(3):541-3. No abstract available.